secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0001641172-25-008988
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel announces 1-for-16 reverse stock split effective May 12, 2025 to meet Nasdaq bid price requirement
--------------------------------------------------------------------------------

- Reverse split ratio of 1-for-16; effective May 12, 2025 at market open.
- Pre-split shares: 356,357,531; post-split shares: 22,272,346 (rounded).
- No fractional shares; rounding rules apply for shares half or more/less than half.
- CUSIP changes to 23254L884; trading symbol remains CYCC on Nasdaq Capital Market.
- Split approved by board and stockholders to regain compliance with Nasdaq minimum bid price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225008988/0001641172-25-008988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225008988/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer